Treatment with Ohtuvayre in COPD was linked to improved lung function and other benefits across key patient subgroups in ...

Cruises are a great way for travelers with COPD to see the world. Most large cruise lines allow passengers to travel with ...

The global pulmonary arterial hypertension treatment market is on track to achieve significant growth over the next decade, with a projected valuation of USD 7,224.4 million by 2033. This expansion ...

Levalbuterol and albuterol act quickly to open your airways during an asthma attack. Find out more about key differences and ...

N-acetylcysteine (NAC) nebulizer therapy is effective and safe in the short-term (12 weeks) for reducing phlegm in COPD.

Liquidia, Pharmosa Biopharm expand collaboration to develop sustained release inhaled treprostinil: Morrisville, North Carolina Friday, October 4, 2024, 16:00 Hrs [IST] Liquidia C ...

MannKind's (MNKD) stock surged 73%, driven by its 9% royalty stake in Tyvaso DPI. It has strong liquidity. Click here to see ...

To protect your loved one, please do not visit if you are sick or have a COVID-19 positive test result. Get more resources on masking and COVID-19 precautions. Congenital pulmonary stenosis is a ...

and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company is also developing L606, an investigational sustained-release formulation of treprostinil administered ...

About Pulmonary Arterial Hypertension (PAH ... of treprostinil administered twice-daily with a next-generation nebulizer, and currently markets generic Treprostinil Injection for the treatment ...